Sox2 also has been reported to be aberrantly expressed in pancreatic cancer and contributes to cell proliferation and stemness/dedifferentiation through the regulation of a set of genes controlling G1/S transition [64]. This evidence concerns the gene SOX2 and familial pancreatic carcinoma.